관상동맥 질환 진단용 영상 기기 시장 : 영상기기별, 최종사용자별 - 세계 예측(2025-2030년)

The Coronary Heart Disease Diagnostic Imaging Devices Market was valued at USD 2.36 billion in 2023, expected to reach USD 2.58 billion in 2024, and is projected to grow at a CAGR of 9.63%, to USD 4.50 billion by 2030.

The scope of coronary heart disease diagnostic imaging devices encompasses technologies used to visualize the heart and its structure for diagnosing conditions like stenosis or ischemia. This includes modalities such as CT, MRI, and nuclear imaging. These devices are essential in preventing heart disease progression and can significantly aid in crafting personalized treatment plans. In terms of application, they are widely used in hospitals, diagnostic centers, and clinics, given their role in diagnosing coronary blockages and evaluating heart function. End-users predominantly include cardiology departments and research institutions focusing on cardiovascular health. The market grows due to increasing heart disease prevalence, technological advancements in imaging devices, and greater demand for non-invasive procedures. Additionally, an aging global population and rising awareness about early detection heighten the market's growth prospects. Potential opportunities lie in developing AI-powered imaging for enhanced accuracy and software advances that reduce radiation exposure during scans. Investing in portable and cost-effective imaging solutions for emerging markets presents another lucrative opportunity. However, market growth faces challenges such as high costs associated with advanced imaging technologies and regulatory constraints that delay approvals and market entry. Budget constraints in healthcare systems and a shortage of skilled radiologists also pose barriers in many regions. Innovation lies in improving imaging efficiency and precision, developing user-friendly interfaces, and integrating telemedicine capabilities with diagnostic devices to facilitate remote consultations. By focusing on research in AI algorithms for early disease detection and investing in the miniaturization of imaging technologies, companies can stay ahead. The market remains competitive and dynamic, underscored by the continuous push for better resolution and lower costs, suggesting a high potential for growth and innovation in enhancing the affordability and accessibility of diagnostic imaging solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronary Heart Disease Diagnostic Imaging Devices Market

The Coronary Heart Disease Diagnostic Imaging Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased prevalence of obesity due to rising number of coronary artery diseases (CAD)
  • Need for non-invasive diagnostic techniques for the rising geriatric population
  • Demand for pocket-sized cardiovascular ultrasound systems
• Market Restraints
  • High cost of coronary heart disease diagnostic imaging devices
• Market Opportunities
  • Rapid adoption of advanced 3-D imaging techniques and AI-enabled medical imaging equipment
  • Technological advancements and new product launches of the coronary heart disease diagnostic imaging devices
• Market Challenges
  • Frequent product recalls of the devices

Porter's Five Forces: A Strategic Tool for Navigating the Coronary Heart Disease Diagnostic Imaging Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronary Heart Disease Diagnostic Imaging Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronary Heart Disease Diagnostic Imaging Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronary Heart Disease Diagnostic Imaging Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronary Heart Disease Diagnostic Imaging Devices Market

A detailed market share analysis in the Coronary Heart Disease Diagnostic Imaging Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronary Heart Disease Diagnostic Imaging Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronary Heart Disease Diagnostic Imaging Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronary Heart Disease Diagnostic Imaging Devices Market

A strategic analysis of the Coronary Heart Disease Diagnostic Imaging Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Heart Disease Diagnostic Imaging Devices Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert Group, Analogic Corporation, AngioDynamics, Inc., Canon Medical Systems Corporation, Chison Medical Technologies Co., Ltd., Edwards Lifesciences Corporation, Epsilon Imaging, Inc., FUJIFILM Corporation, GE HealthCare Technologies Inc., Heart Test Laboratories, Inc., Hill-Rom Holdings, Inc., Hitachi, Ltd., Koninklijke Philips N.V., LivaNova PLC, Merit Medical Systems, Inc., Mindray Medical International Limited, Siemens AG, Terumo Medical Corporation, TOMTEC Imaging Systems GmbH, Toshiba Corporation, and Translumina GmbH.

Market Segmentation & Coverage

This research report categorizes the Coronary Heart Disease Diagnostic Imaging Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Imaging Devices, market is studied across Computed Tomography, Magnetic Resonance Imaging Systems, Mammography Systems, Nuclear Imaging Systems, Ultrasound Imaging Systems, and X-Ray Imaging Systems.
• Based on End-User, market is studied across Diagnostic Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased prevalence of obesity due to rising number of coronary artery diseases (CAD)
    • 5.1.1.2. Need for non-invasive diagnostic techniques for the rising geriatric population
    • 5.1.1.3. Demand for pocket-sized cardiovascular ultrasound systems
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of coronary heart disease diagnostic imaging devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Rapid adoption of advanced 3-D imaging techniques and AI-enabled medical imaging equipment
    • 5.1.3.2. Technological advancements and new product launches of the coronary heart disease diagnostic imaging devices
  • 5.1.4. Challenges
    • 5.1.4.1. Frequent product recalls of the devices
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Coronary Heart Disease Diagnostic Imaging Devices Market, by Imaging Devices

• 6.1. Introduction
• 6.2. Computed Tomography
• 6.3. Magnetic Resonance Imaging Systems
• 6.4. Mammography Systems
• 6.5. Nuclear Imaging Systems
• 6.6. Ultrasound Imaging Systems
• 6.7. X-Ray Imaging Systems

7. Coronary Heart Disease Diagnostic Imaging Devices Market, by End-User

• 7.1. Introduction
• 7.2. Diagnostic Centers
• 7.3. Hospitals

8. Americas Coronary Heart Disease Diagnostic Imaging Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Coronary Heart Disease Diagnostic Imaging Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Coronary Heart Disease Diagnostic Imaging Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agfa-Gevaert Group
• 2. Analogic Corporation
• 3. AngioDynamics, Inc.
• 4. Canon Medical Systems Corporation
• 5. Chison Medical Technologies Co., Ltd.
• 6. Edwards Lifesciences Corporation
• 7. Epsilon Imaging, Inc.
• 8. FUJIFILM Corporation
• 9. GE HealthCare Technologies Inc.
• 10. Heart Test Laboratories, Inc.
• 11. Hill-Rom Holdings, Inc.
• 12. Hitachi, Ltd.
• 13. Koninklijke Philips N.V.
• 14. LivaNova PLC
• 15. Merit Medical Systems, Inc.
• 16. Mindray Medical International Limited
• 17. Siemens AG
• 18. Terumo Medical Corporation
• 19. TOMTEC Imaging Systems GmbH
• 20. Toshiba Corporation
• 21. Translumina GmbH